Get the Stockscreener App
277.44
2.17%
-6.05
Overview
News
Price History
Option Chain
Financials
Discussions
Forecast
Stock Split
Dividend History
Factset Research Systems Inc stock is traded at $277.44, with a volume of 182.11K.
It is down -2.17% in the last 24 hours and up +7.45% over the past month.
FactSet provides financial data and portfolio analytics to the global investment community. The company aggregates data from third-party data suppliers, news sources, exchanges, brokerages, and contributors into its workstations. In addition, it provides essential portfolio analytics that companies use to monitor portfolios and address reporting requirements. Buy-side clients (including wealth and corporate clients) account for over 80% of FactSet's annual subscription value. In 2015, the company acquired Portware, a provider of trade execution software. In 2017, it acquired BISAM, a risk management and performance measurement provider. In 2022, it completed its purchase of CUSIP Global Services.
See More
Previous Close:
$283.49
Open:
$281.5
24h Volume:
182.11K
Relative Volume:
0.20
Market Cap:
$9.87B
Revenue:
$2.40B
Net Income/Loss:
$587.79M
P/E Ratio:
17.85
EPS:
15.5461
Net Cash Flow:
$682.87M
1W Performance:
-2.39%
1M Performance:
+7.45%
6M Performance:
+45.92%
1Y Performance:
-24.97%
1-Day Range:
$274.95
$282.22
1-Week Range:
$274.33
$289.45
52-Week Range:
$185.00
$387.75
Factset Research Systems Inc Stock (FDS) Company Profile
Name
Factset Research Systems Inc
Sector
Phone
(203) 810-1000
Address
45 GLOVER AVENUE, NORWALK, CT
Compare FDS vs SPGI, CME, ICE, MCO, NDAQ
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
FDS
Factset Research Systems Inc
|
277.48 | 10.08B | 2.40B | 587.79M | 682.87M | 15.55 |
SPGI
S P Global Inc
|
411.31 | 123.46B | 15.73B | 5.15B | 5.56B | 15.81 |
CME
Cme Group Inc
|
268.64 | 97.01B | 6.76B | 4.26B | 4.33B | 11.72 |
ICE
Intercontinental Exchange Inc
|
154.79 | 86.86B | 12.93B | 3.99B | 4.24B | 6.8684 |
MCO
Moodys Corp
|
479.33 | 83.99B | 7.87B | 2.50B | 2.75B | 13.95 |
NDAQ
Nasdaq Inc
|
96.69 | 54.23B | 8.27B | 1.91B | 2.00B | 3.3193 |
Factset Research Systems Inc Stock (FDS) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Feb-17-26 | Resumed | BofA Securities | Underperform |
| Dec-17-25 | Upgrade | Morgan Stanley | Underweight → Equal-Weight |
| Sep-22-25 | Upgrade | UBS | Neutral → Buy |
| Sep-12-25 | Upgrade | Rothschild & Co Redburn | Sell → Neutral |
| Jun-26-25 | Upgrade | Raymond James | Underperform → Mkt Perform |
| Mar-21-25 | Downgrade | Wells Fargo | Equal Weight → Underweight |
| Oct-09-24 | Downgrade | Redburn Atlantic | Neutral → Sell |
| Oct-02-24 | Initiated | Evercore ISI | In-line |
| Aug-13-24 | Initiated | Wells Fargo | Equal Weight |
| May-30-24 | Downgrade | BofA Securities | Neutral → Underperform |
| Apr-11-24 | Initiated | Wolfe Research | Underperform |
| Mar-22-24 | Downgrade | Barclays | Overweight → Equal Weight |
| Dec-08-23 | Downgrade | Deutsche Bank | Buy → Hold |
| Aug-25-23 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
| Jun-15-23 | Resumed | BofA Securities | Neutral |
| May-15-23 | Initiated | BMO Capital Markets | Market Perform |
| May-09-23 | Initiated | Wells Fargo | Equal Weight |
| Mar-28-23 | Upgrade | Redburn | Sell → Neutral |
| Jan-12-23 | Upgrade | Credit Suisse | Neutral → Outperform |
| Aug-26-22 | Upgrade | Deutsche Bank | Hold → Buy |
| May-17-22 | Initiated | Redburn | Sell |
| Mar-30-22 | Initiated | Deutsche Bank | Hold |
| Dec-14-21 | Upgrade | Northcoast | Sell → Neutral |
| Sep-30-21 | Upgrade | UBS | Sell → Neutral |
| Aug-25-21 | Upgrade | Barclays | Equal Weight → Overweight |
| Jul-08-21 | Initiated | RBC Capital Mkts | Outperform |
| Jun-11-20 | Downgrade | Northcoast | Neutral → Sell |
| Jun-01-20 | Resumed | Oppenheimer | Perform |
| Nov-22-19 | Initiated | Jefferies | Hold |
| Sep-27-19 | Downgrade | BofA/Merrill | Neutral → Underperform |
| Jul-16-19 | Downgrade | Morgan Stanley | Equal-Weight → Underweight |
| Jun-27-19 | Downgrade | Goldman | Neutral → Sell |
| Dec-07-18 | Upgrade | Barclays | Underweight → Equal Weight |
| Dec-07-18 | Resumed | Credit Suisse | Neutral |
| Dec-05-17 | Downgrade | Northcoast | Buy → Neutral |
| Nov-08-17 | Initiated | Goldman | Neutral |
| Sep-21-17 | Upgrade | Northcoast | Neutral → Buy |
| Jan-10-17 | Downgrade | Barclays | Equal Weight → Underweight |
| Sep-27-16 | Downgrade | Raymond James | Mkt Perform → Underperform |
| Aug-26-16 | Initiated | Macquarie | Neutral |
| Jul-12-16 | Initiated | Credit Suisse | Outperform |
| Mar-22-16 | Initiated | Sterne Agee CRT | Neutral |
| Mar-16-16 | Downgrade | Stifel | Buy → Hold |
| Mar-10-16 | Downgrade | UBS | Neutral → Sell |
| Dec-08-15 | Reiterated | Stifel | Buy |
| Nov-10-15 | Initiated | Cantor Fitzgerald | Hold |
View All
Factset Research Systems Inc Stock (FDS) Latest News
FactSet Research Systems (FDS) Discounted Despite AI Workflow Integration - Yahoo Finance
Medical Properties Trust, Inc. Stock 12‑Month Price Target Cut to $5.11, Implies 22% Upside - TradingView
Allegiant Travel Company Stock 12‑Month Price Target Cut to $135.79, Implies 58% Upside - TradingView
NCPL Q4'25 Earnings: EPS estimate is (0.26) USD - TradingView
PRE Q2'26 Earnings: EPS estimate is (0.84) USD - TradingView
KEYS Q3'26 Earnings: EPS estimate is 2.48 USD - TradingView
CAAP Q2'26 Earnings: EPS estimate is 0.50 USD - TradingView
Workday, Inc. Stock 12‑Month Price Target Raised to $180.42, Implies 9% Downside - TradingView
Apple Inc. Stock 12‑Month Price Target Raised to $334.23, Implies 9% Upside - TradingView
FactSet Research stock holds steady as dividend and valuation support the story - AD HOC NEWS
Barings BDC, Inc. Stock 12‑Month Price Target Raised to $9.96, Implies 7% Upside - TradingView
Contineum Therapeutics, Inc. Stock 12‑Month Price Target Raised to $23.14, Implies 63% Upside - TradingView
New York Times Company (The) Stock 12‑Month Price Target Cut to $76.29, Implies 18% Upside - tradingview.com
New Mountain Finance Corporation Stock 12‑Month Price Target Raised to $8.45, Implies 9% Upside - TradingView
enGene Therapeutics Inc. Stock 12‑Month Price Target Cut to $3.43, Implies 102% Upside - TradingView
Blue Bird Corporation Stock 12‑Month Price Target Raised to $90.14, Implies 39% Upside - TradingView
Qfin Holdings, Inc. Stock 12‑Month Price Target Cut to $20.64, Implies 68% Upside - TradingView
FactSet Research Systems Inc. stock underperforms Friday when compared to competitors - MarketWatch
Ryman Hospitality Properties, Inc. (REIT) Stock 12‑Month Price Target Cut to $134.71, Implies 8% Upside - TradingView
Suncrete, Inc. Stock 12‑Month Price Target Cut to $23.5, Implies 25% Upside - TradingView
Satellos Bioscience Inc. Stock 12‑Month Price Target Cut to $21.78, Implies 122% Upside - TradingView
Gemini Space Station, Inc. Stock 12‑Month Price Target Cut to $6.06, Implies 41% Upside - TradingView
Blaize Holdings, Inc. Stock 12‑Month Price Target Cut to $1.8, Implies 54% Upside - TradingView
Performance Food Group Company Stock 12‑Month Price Target Raised to $130.27, Implies 25% Upside - TradingView
Nu Holdings Ltd. Stock 12‑Month Price Target Raised to $18.01, Implies 29% Upside - TradingView
KinderCare Learning Companies, Inc. Stock 12‑Month Price Target Cut to $4.13, Implies 15% Downside - TradingView
Brinker International, Inc. Stock 12‑Month Price Target Raised to $272, Implies 14% Upside - TradingView
Alto Neuroscience, Inc. Stock 12‑Month Price Target Raised to $37.56, Implies 16% Upside - TradingView
American Eagle Outfitters, Inc. Stock 12‑Month Price Target Cut to $19.5, Implies 20% Upside - tradingview.com
Sana Biotechnology, Inc. Stock 12‑Month Price Target Cut to $9.38, Implies 155% Upside - TradingView
Satellos Bioscience Inc. Stock 12‑Month Price Target Cut to $21.92, Implies 123% Upside - TradingView
Jefferson Capital, Inc. Stock 12‑Month Price Target Raised to $27.29, Implies 26% Upside - TradingView
Eikon Therapeutics, Inc. Stock 12‑Month Price Target Cut to $24.6, Implies 138% Upside - TradingView
Erasca, Inc. Stock 12‑Month Price Target Raised to $23, Implies 29% Upside - TradingView
Caribou Biosciences, Inc. Stock 12‑Month Price Target Cut to $11.86, Implies 636% Upside - TradingView
Candel Therapeutics, Inc. Stock 12‑Month Price Target Raised to $20.88, Implies 77% Upside - TradingView
Applied Materials, Inc. Stock 12‑Month Price Target Raised to $654.18, Implies 22% Upside - TradingView
York Space Systems Inc. Stock 12‑Month Price Target Cut to $31.78, Implies 176% Upside - TradingView
Nu Holdings Ltd. Stock 12‑Month Price Target Raised to $17.73, Implies 27% Upside - TradingView
Credicorp Ltd. Stock 12‑Month Price Target Raised to $436.51, Implies 16% Upside - TradingView
SONM Q2'26 Earnings: EPS estimate is 5.22 USD - TradingView
SCNX Q2'26 Earnings: EPS estimate is (0.09) USD - TradingView
NSPR Q2'26 Earnings: EPS estimate is (0.20) USD - TradingView
NRXP Q2'26 Earnings: EPS estimate is (0.11) USD - TradingView
HMR Q2'26 Earnings: EPS estimate is 0.05 USD - TradingView
BJ Q2'26 Earnings: revenue estimate is 5.97B USD - TradingView
POSCO HOLDINGS INC. Stock 12‑Month Price Target Cut to $77.63, Implies 37% Upside - TradingView
Lear Corporation Stock 12‑Month Price Target Cut to $149, Implies 21% Upside - TradingView
Knife Riv Holding Co. Stock 12‑Month Price Target Cut to $92.71, Implies 41% Upside - TradingView
Credicorp Ltd. Stock 12‑Month Price Target Raised to $437.02, Implies 16% Upside - TradingView
SoundThinking, Inc. Stock 12‑Month Price Target Cut to $12.67, Implies 53% Upside - TradingView
Factset Research Systems Inc Stock (FDS) Financials Data
Revenue
Net Income
Cash Flow
EPS
2.21%
1.48%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):